BCL-2 INHIBITOR ABT-199 REDUCES RESISTANCE OF HIV RESERVOIRS TO CD8+ T-CELL KILLING

Venclexta (venetoclax) - Roche, AbbVie

bryostatin 1 (NSC 339555) - Neurotrope BioScience

http://www.croiconference.org/sessions/bcl-2-inhibitor-abt-199-reduces-resistance-hiv-reservoirs-cd8-t-cell-killing

Szuhan Huang1; Shabnum Patel2; Yanqin Ren2; Ronald Truong2; Dean Magat2; Chase McCann2; Shuntai Zhou3; Sabrina Clark3; Elizabeth A. Zale2; Amanda Macedo2; Talia Mota2; Ronald Swanstrom3; Alberto Bosque2; Catherine M. Bollard4; R. Brad Jones2

Mar 8, 2019